How can we help?
Viral Marker Screening (HIV, HBsAg, Anti-HCV)

Viral Marker Screening (HIV, HBsAg, Anti-HCV) near me in Faridabad

Also referred as
Triple H (HIV
HBV
HCV)
+2
HIV Combo+HbsAg+Anti-HCV
Screening-CMIA/CLIA
For men & women
Earliest reports in
18 hours
Contains
3 tests
Know more about this test

A Viral Marker Screening (HIV, HBsAg, Anti-HCV) test, also known as the Triple H test, helps screen for infections caused by three significant viruses: Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV). This test detects the presence of viral markers, including antigens and antibodies, produced by the body in response to hepatitis B, hepatitis C, or HIV infections. Also, it helps determine the stage of infection, assess the immune response, and monitor treatment response. It is available at an affordable price in Faridabad with Tata 1mg Labs. 

Your doctor may suggest a Triple H (HIV, HBV, HCV) test if you have risk factors for HIV, HBV, or HCV infections, including weakened immunity, unsafe sexual practices, intravenous drug use, occupational exposure to blood, or potential exposure through medical procedures. Additionally, a Triple H (HIV, HBV, HCV) test may also be done in pregnant women as a part of prenatal care, as these infections can be transmitted from a mother to her unborn child. 

No special preparation is needed for this test. However, it is mandatory to fill out a consent form for HIV testing and undergo pre-test counseling (Annexure - CR/01) before sample collection. 

Samples required
Blood
Find out
Why is this test booked?
Preparation for this test
Sample Collection
Who will collect your samples?

Understanding Viral Marker Screening (HIV, HBsAg, Anti-HCV)

HIV causes acquired immunodeficiency syndrome (AIDS) and attacks the immune cells that help the body fight infection, making an individual more vulnerable to other infections and diseases. Hepatitis B and C are highly contagious infections and are caused by the hepatitis B virus (HBV) and hepatitis C virus(HCV), respectively. Chronic HBV or HCV infections can lead to liver damage and other complications. A Viral Marker Screening (HIV, HBsAg, Anti-HCV) test detects the presence of viral markers, including antigens and antibodies, produced by the body in response to hepatitis B, hepatitis C, or HIV infections.

People with HIV are most likely to get infected by chronic hepatitis. This co-infection causes more liver-related health problems. Hence, given the risk of co-infection, it is crucial to recognize these risks early with a Viral Marker Screening (HIV, HBsAg, Anti-HCV) test, take preventive measures, and, if necessary, seek medical attention.

Your doctor may suggest a Viral Marker Screening (HIV, HBsAg, Anti-HCV) test if you have risk factors for HIV, HBV, or HCV infections, including a weakened immunity, unsafe sexual practices, intravenous drug use, occupational exposure to blood, or potential exposure through medical procedures. Additionally, a Viral Marker Screening (HIV, HBsAg, Anti-HCV) test may also be done in pregnant women as a part of prenatal care as these infections can be transmitted from a mother to her unborn child.

Before getting tested, let your doctor know about all the medications you are taking, as some of them can affect the test results, and you might be asked to stop taking them. Also, a duly filled consent form is mandatory for sample collection.

A Viral Marker Screening (HIV, HBsAg, Anti-HCV) test utilizes automated chemiluminescence immunoassay technology for the estimation of HBsAg, anti-HCV antibodies and combined qualitative determination of p24 antigen and specific antibodies to HIV (1 & 2). The technology (CMIA/ CLIA) can vary based on different machines available in different locations.

Test results depend upon various factors such as clinical history, time of sample collection, etc. Discuss your specific test results with your doctor. Based on your test results, doctors may suggest some lifestyle adjustments, prescribe medications to manage your condition, and develop a holistic treatment plan.

See more

What does Viral Marker Screening (HIV, HBsAg, Anti-HCV) measure?

Contains 3 tests

A Viral Marker Screening (HIV, HBsAg, Anti-HCV) test includes screening of three transmissible viral infections, namely hepatitis B surface antigen, hepatitis C virus antibody, and HIV combo (antigen and antibody) test. These tests evaluate the presence or absence of the viruses causing hepatitis B or C and acquired immunodeficiency syndrome (AIDS) in your blood sample.

HIV Combo (antigen and antibody) test simultaneously detects HIV p24 antigen and antibodies associated with HIV 1 & 2. The HIV p24 antigen is the most abundant HIV protein and its detection is used clinically to diagnose an HIV infection early on since HIV-specific antibodies are not detectable in a very recently acquired infection. HIV-1 was discovered first and is the most widespread, whereas HIV-2 is more than 55% genetically different from HIV-1. The transmission rate of HIV-2 is also slower than HIV-1. This test also helps to differentiate between the two HIV infections.

Hepatitis B surface antigen test screens for the presence of hepatitis B virus (HBV) in an individual. HBsAg is the first serological marker, within 1 to 10 weeks, to appear in the blood after recent exposure to HBV. Persistence of this marker for more than 6 months implies chronic (long-term) HBV infection, which may lead to liver damage (scarring or cirrhosis). A person who has a chronic infection is capable of spreading the infection to healthy individuals, even if they do not show or experience any symptoms.

The hepatitis C virus antibody test determines if you have been infected by the hepatitis C virus (HCV) and helps your doctor guide your treatment. HCV causes liver inflammation and is classified into acute hepatitis infection and chronic hepatitis infection .This test is used for screening for anti-HCV antibodies.

  • Acute hepatitis C: This occurs in the first six months after exposure to the hepatitis C virus. In the early stage of the infection, acute hepatitis C is mild and may cause no symptoms. For this reason, most people do not know they have this infection.
  • Chronic hepatitis C: If your body is unable to fight off the virus, you can develop a chronic hepatitis C infection. Progression from acute to chronic hepatitis C is common, occurring in about 75-85% of patients. Detecting chronic hepatitis C at the early stage is important to prevent future complications, such as liver failure, and initiate effective treatment.

The Hepatitis C Virus (HCV) Antibody test determines the status of current hepatitis C virus (HCV) infection or past HCV infection that has been resolved. This test, therefore, helps your doctor to guide an appropriate treatment plan. HCV causes liver inflammation and is classified into acute hepatitis infection and chronic hepatitis infection.

  • Acute hepatitis C: This occurs in the first six months after exposure to the hepatitis C virus. In the early stage of the infection, acute hepatitis C is mild and may cause no symptoms. For this reason, most people do not know they have this infection.
  • Chronic hepatitis C: If your body is unable to fight off the virus, you can develop a chronic hepatitis C infection. Progression from acute to chronic hepatitis C is common, occurring in about 75-85% of patients. Detecting chronic hepatitis C at the early stage is important to prevent future complications, such as liver failure, and initiate effective treatment.

The Hepatitis C Virus (HCV) Antibody test is used for screening for anti-HCV antibodies. A reactive result needs to be confirmed by other more specific NAT/ nucleic acid tests before final diagnosis.

 

Know more about Hepatitis C Virus (HCV) Antibody

The Hepatitis B Surface Antigen (HBsAg) test detects the presence of a specific protein on the surface of the Hepatitis B virus (HBV) in the bloodstream. This protein, HBsAg, serves as a crucial marker for identifying HBV infection. This is a screening test and the diagnosis of any reactive HBsAg result relies on additional supplemental tests like anti-HBs antibody and total anti-HBc antibodies. Confirmation can be done using nucleic acid tests like HBV DNA by PCR. The Hepatitis B Surface Antigen (HBsAg) test is essential for identifying individuals who require medical intervention, such as antiviral therapy, and for implementing measures to prevent the spread of Hepatitis B virus to others. 

Know more about Hepatitis B Surface Antigen (HBsAg)

An HIV Combo (Antigen And Antibody) Test simultaneously detects HIV p24 antigen and antibodies associated with HIV 1 & 2. The HIV p24 antigen is the most abundant HIV protein and its detection is used clinically to diagnose an HIV infection early on since HIV-specific antibodies are not detectable in a very recently acquired infection. HIV-1 was discovered first and is the most widespread, whereas HIV-2 is more than 55% genetically different from HIV-1. The transmission rate of HIV-2 is also slower than HIV-1. 

Know more about HIV Combo (Antigen And Antibody) Test

FAQs related to Viral Marker Screening (HIV, HBsAg, Anti-HCV) in Faridabad

A Viral Marker Screening (HIV, HBsAg, Anti-HCV) test is a screening procedure usually done if you exhibit signs and symptoms suggestive of viral hepatitis B or C and HIV infections. It is suggested as a screening test before all elective or emergency procedures and during pregnancy. This test is also suggested for people who have higher risk factors like sharing needles, abusing intravenous drugs, and indulging in unprotected sexual activities.
The symptoms that require a Viral Marker Screening (HIV, HBsAg, Anti-HCV) test may vary from person to person depending upon the type of virus exposed. However, some of the most common signs that may need a viral marker test are flu-like symptoms (fever, headache, vomiting, abdominal pain), jaundice symptoms (like yellowing of the skin and the whites of the eyes), unexplained weight loss, night sweats, persistent cough rashes on the skin, etc.
Standard precautions for blood tests should be followed. You should also inform your doctor about any medications or supplements you are taking as they could potentially interfere with the test results.
Yes, you can book a Viral Marker Screening (HIV, HBsAg, Anti-HCV) test in Faridabad near you with Tata 1mg Labs. The test can be booked easily, is affordable, and comes with an easy-to-understand report.
Yes, home sample collection is possible for a Viral Marker Screening (HIV, HBsAg, Anti-HCV) test in Faridabad with Tata 1mg Labs. You can also choose a date and time that suits your schedule for sample collection.
The booking process for a Triple Viral Marker Screening test with Tata 1mg Labs in Faridabad is straightforward and hassle-free. Follow these steps to schedule a test online: 1). Go to the Lab Tests section on the Tata 1mg website. 2). Add your preferred test to the shopping cart. 3). Choose a time and day that works for you as long as you also take the essential prerequisites into account. 4). A confirmation notification will be sent to you with all the details once the booking is complete.
Tata 1mg Labs allows you to book tests at an affordable price in Faridabad. A Triple Viral Marker Screening test can be booked at a pocket-friendly budget of Rs. 1409.
We at Tata 1mg Labs recognize the value of prompt results. We strive to deliver test results with quick turnaround times so you can receive the information promptly. The reports of a Viral Marker Screening (HIV, HBsAg, Anti-HCV) test in Faridabad are often provided in 18 hours.

Viral Marker Screening (HIV, HBsAg, Anti-HCV) test price for other cities

How does home sample collection work?

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Download the Tata 1mg app. Trusted healthcare, at your fingertips.

Book tests, track reports, and get AI-powered health insights.

or

Other tests

Test conducted by
PEME Gurgaon - UAT
Know More
Contains 3 tests
Hepatitis C Virus (HCV) Antibody
Hepatitis B Surface Antigen (HBsAg)
HIV Combo (Antigen And Antibody) Test